scholarly article | Q13442814 |
P50 | author | Franklin D Rumjanek | Q37834086 |
P2093 | author name string | Nívea Dias Amoêdo | |
Antonio Galina | |||
Mariana Figueiredo Rodrigues | |||
Juan Perez Valencia | |||
P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function | Q24306243 | ||
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate | Q24320239 | ||
Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis | Q24337960 | ||
Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria | Q24595940 | ||
Targeting cellular metabolism to improve cancer therapeutics | Q24596727 | ||
The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate | Q24605258 | ||
Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy | Q24646296 | ||
HIF-1: upstream and downstream of cancer metabolism | Q24647482 | ||
An integrated genomic analysis of human glioblastoma multiforme | Q24648860 | ||
Cancer metabolism: Key players in metabolic reprogramming | Q26827663 | ||
Mitochondrial localization and structure-based phosphate activation mechanism of Glutaminase C with implications for cancer metabolism | Q27676639 | ||
Glycolysis inhibition for anticancer treatment | Q28256222 | ||
Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells | Q28270014 | ||
Energy metabolism in tumor cells | Q28288377 | ||
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia | Q29616650 | ||
Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis | Q29617613 | ||
Tumor cell metabolism: cancer's Achilles' heel | Q29619809 | ||
Alternative fuel--another role for p53 in the regulation of metabolism | Q33841854 | ||
Molecular cloning of a cDNA for rat hepatic glutaminase. Sequence similarity to kidney-type glutaminase. | Q34020040 | ||
Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP. | Q34355664 | ||
Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase | Q34517998 | ||
Transport and cytotoxicity of the anticancer drug 3-bromopyruvate in the yeast Saccharomyces cerevisiae | Q62663288 | ||
3-Bromopyruvate inhibits calcium uptake by sarcoplasmic reticulum vesicles but not SERCA ATP hydrolysis activity | Q83462833 | ||
Assessing mitochondrial dysfunction in cells. | Q34793639 | ||
Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond | Q34875637 | ||
Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability | Q35621293 | ||
Mitochondrial metabolism in cancer metastasis: visualizing tumor cell mitochondria and the "reverse Warburg effect" in positive lymph node tissue | Q35954906 | ||
MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors | Q36489907 | ||
Glutamine, gene expression, and cell function | Q36664320 | ||
New cancer targets emerging from studies of the Von Hippel‐Lindau tumor suppressor protein | Q36668449 | ||
Metabolic changes during ovarian cancer progression as targets for sphingosine treatment. | Q36953297 | ||
New insights into brain glutaminases: beyond their role on glutamatergic transmission. | Q37476067 | ||
Regulation of Metabolism by Hypoxia-Inducible Factor 1 | Q37904524 | ||
Potentiation of Anti-Cancer Treatment by Modulators of Energy Metabolism | Q37971489 | ||
Metabolic symbiosis in cancer: Refocusing the Warburg lens | Q37974107 | ||
Availability, not respiratory capacity governs oxygen consumption of solid tumors | Q38016027 | ||
Yeast ATP-Binding Cassette Transporters Conferring Multidrug Resistance | Q38019037 | ||
Mitochondrial dysfunction and cancer metastasis | Q38034647 | ||
Regulation of metastasis; mitochondrial DNA mutations have appeared on stage | Q38034936 | ||
The scarlet letter of alkylation: a mini review of selective alkylating agents. | Q38039421 | ||
Mitoplasticity: Adaptation Biology of the Mitochondrion to the Cellular Redox State in Physiology and Carcinogenesis | Q38044495 | ||
Mitochondrial complex II, a novel target for anti-cancer agents | Q38059007 | ||
Effect of the antitumoral alkylating agent 3-bromopyruvate on mitochondrial respiration: role of mitochondrially bound hexokinase | Q39398652 | ||
Quantifying reductive carboxylation flux of glutamine to lipid in a brown adipocyte cell line | Q39998829 | ||
PKM2, a Central Point of Regulation in Cancer Metabolism | Q41669982 | ||
Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate | Q46302698 | ||
Drug resistance: the fight against fungi | Q46666904 | ||
P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | neoplasm | Q1216998 |
energy metabolism | Q30225378 | ||
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P577 | publication date | 2013-11-15 | |
P13046 | publication type of scholarly work | review article | Q7318358 |
P1433 | published in | Bioscience Reports | Q2790714 |
P1476 | title | How does the metabolism of tumour cells differ from that of normal cells | |
P478 | volume | 33 |
Q38946644 | 3-Bromopyruvate induces rapid human prostate cancer cell death by affecting cell energy metabolism, GSH pool and the glyoxalase system. |
Q42271569 | Acidic cellular microenvironment modifies carcinogen-induced DNA damage and repair |
Q41072362 | Active hexose-correlated compound enhances extrinsic-pathway-mediated apoptosis of Acute Myeloid Leukemic cells |
Q28604225 | Ammonium ions improve the survival of glutamine-starved hybridoma cells |
Q26775580 | Breast Cancer Metabolism and Mitochondrial Activity: The Possibility of Chemoprevention with Metformin |
Q88870043 | Development of novel amino-quinoline-5,8-dione derivatives as NAD(P)H:quinone oxidoreductase 1 (NQO1) inhibitors with potent antiproliferative activities |
Q64250489 | Doxorubicin Loaded Magnesium Oxide Nanoflakes as pH Dependent Carriers for Simultaneous Treatment of Cancer and Hypomagnesemia |
Q91750497 | Dysregulation of Glucose Metabolism by Oncogenes and Tumor Suppressors in Cancer Cells |
Q36037821 | EGFR Signal-Network Reconstruction Demonstrates Metabolic Crosstalk in EMT. |
Q46617301 | Effect of 3-bromopyruvate acid on the redox equilibrium in non-invasive MCF-7 and invasive MDA-MB-231 breast cancer cells. |
Q38654624 | Effect of steviol, steviol glycosides and stevia extract on glucocorticoid receptor signaling in normal and cancer blood cells |
Q38774452 | Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation |
Q26781703 | Gamma-enolase: a well-known tumour marker, with a less-known role in cancer |
Q38903447 | Glycolytic Coupling to Mitochondrial Energy Production Ensures Survival in an Oxygen Rich Environment |
Q42339288 | Hyperglycemia exacerbates colon cancer malignancy through hexosamine biosynthetic pathway |
Q38495907 | Hypoxia defined as a common culprit/initiation factor in mitochondrial-mediated proinflammatory processes |
Q58732624 | Identification of Intracellular and Extracellular Metabolites in Cancer Cells Using C Hyperpolarized Ultrafast Laplace NMR |
Q37694431 | Impact of Metabolism on T-Cell Differentiation and Function and Cross Talk with Tumor Microenvironment |
Q46202638 | Infrared imaging: a potential powerful tool for neuroimaging and neurodiagnostics |
Q61796733 | Investigating the Effects of Stove Emissions on Ocular and Cancer Cells |
Q50969598 | Metabolic phenotyping of human blood plasma: a powerful tool to discriminate between cancer types? |
Q36115786 | Modulator of apoptosis 1 (MOAP-1) is a tumor suppressor protein linked to the RASSF1A protein. |
Q36683880 | Nuclear receptors and the Warburg effect in cancer |
Q90133640 | Single Cell Mass Cytometry of Non-Small Cell Lung Cancer Cells Reveals Complexity of In vivo And Three-Dimensional Models over the Petri-dish |
Q90249858 | Styryl-cinnamate hybrid inhibits glioma by alleviating translation, bioenergetics and other key cellular responses leading to apoptosis |
Q91770932 | Targeting Cancer Cells using 3-bromopyruvate for Selective Cancer Treatment |
Q52563269 | The Novel Roles of Connexin Channels and Tunneling Nanotubes in Cancer Pathogenesis |
Q46020509 | The Roles of ROS in Cancer Heterogeneity and Therapy. |
Q38837920 | The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside. |
Search more.